HIGHLIGHTS
- who: August et al. from the National Center for Advancing United States Jadavpur University, India have published the paper: expression is associated with activated ammatory pathways in high-grade serous ovarian cancer, in the Journal: (JOURNAL)
- what: This study aimed at elucidating the expression of SLCO4A1 in patient-derived ovarian cancer cell lines.
SUMMARY
At the molecular level, HGSOC is characterized by mutations in TP53, which contributes to the genetic instability of cancer cells and drug resistance (Ahmed et_al, 2010; Zhou et_al, 2019). Frontiers in Pharmacology frontiersin.org 10.3389/fphar . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.